Search by Drug Name or NDC

    NDC 70518-2573-00 Glipizide 2.5 mg/1 Details

    Glipizide 2.5 mg/1

    Glipizide is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is GLIPIZIDE.

    Product Information

    NDC 70518-2573
    Product ID 70518-2573_048771ab-4520-622c-e063-6294a90ab564
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Glipizide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Glipizide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name GLIPIZIDE
    Labeler Name REMEDYREPACK INC.
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206928
    Listing Certified Through n/a

    Package

    NDC 70518-2573-00 (70518257300)

    NDC Package Code 70518-2573-0
    Billing NDC 70518257300
    Package 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2573-0)
    Marketing Start Date 2020-02-18
    NDC Exclude Flag N
    Pricing Information N/A